Article Text

other Versions

PDF
Monitoring of concordance in growth hormone therapy
  1. Ritika R Kapoor (r.kapoor{at}ich.ucl.ac.uk)
  1. Addenbrooke's Hospital, United Kingdom
    1. Susan Burke
    1. Addenbrooke's Hospital, United Kingdom
      1. Susan Sparrow
      1. Addenbrooke's Hospital, United Kingdom
        1. Ieuan Hughes (iah1000{at}cam.ac.uk)
        1. Addenbrooke's Hospital, United Kingdom
          1. David B Dunger (dbd25{at}cam.ac.uk)
          1. Addenbrooke's Hospital, United Kingdom
            1. Ken Ong
            1. Addenbrooke's Hospital, United Kingdom
              1. Carlo L Acerini (cla22{at}cam.ac.uk)
              1. University of Cambridge, United Kingdom

                Abstract

                Concordance with growth hormone therapy in 75 children was objectively assessed through data on GP prescriptions over 12-months. 23% missed >2 injections/week. Lower concordance was associated with: longer duration on GH therapy (p<0.005), lack of choice of delivery device (p<0.005), and short prescription durations (p<0.005), and predicted lower height velocities (p<0.05).

                • concordance
                • growth hormone therapy
                • objective monitoring

                Statistics from Altmetric.com

                Request permissions

                If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                Linked Articles